Promotional Products for Pharmaceutical Companies

Pharmaceutical marketing compliance is genuinely more nuanced than a single global rule, and the picture changes meaningfully depending on which market you're operating in. This guide focuses specifically on the regulatory reality across Pen Promo's core markets — Turkey, Iraq, and the Gulf — rather than defaulting to the U.S.-centric framing common in most industry content on this topic.

The Regulatory Reality Varies Significantly by Market

Turkey applies one of the strictest regimes in the region. Under Article 6/8 of Turkey's Regulation on Promotion Activities of Medicinal Products, no monetary or in-kind benefit — regardless of value — may be provided to physicians, dentists, or pharmacists during promotional activity. Under a strict reading, even a low-cost item bearing a product name can raise a compliance concern. Companies marketing pharmaceuticals to Turkish healthcare professionals should treat branded-item gifting to prescribers as effectively off the table.

Saudi Arabia takes a more structured but less absolute approach. The Saudi Food and Drug Authority's ethical code permits in-kind gifts to healthcare professionals specifically when the item bears the trade name or generic name of the product being promoted — a materially different standard than Turkey's near-total prohibition. Notably, published physician survey research in Saudi Arabia found a large majority of surveyed physicians reported having received gifts from pharmaceutical representatives, suggesting the practice remains common even where a formal ethical code exists — a reminder that documented rules and everyday practice don't always align, and that formal compliance still requires following the code's specific conditions rather than relying on common practice alone.

The UAE imposes strict, detailed controls on hospitality and gifts to healthcare professionals and caps free goods provided to pharmacies, but its framework is structured differently from Turkey's blanket ban — confirm current specifics with your compliance team for any UAE-facing campaign.

Iraq does not appear to have as detailed or internationally documented a regulatory framework as its neighbors — in practice, this often means enforcement is less standardized, but it does not mean no rules apply; local counsel familiar with current Iraqi health authority requirements should still be consulted.

What This Means Practically

• For Turkey-facing marketing, plan around the assumption that branded items to prescribers are not permitted, and focus promotional budget on the compliant categories covered below.
• For Saudi Arabia, branded items carrying the specific product's trade or generic name may be permissible within the SFDA code's conditions — confirm the exact requirements (documentation, value limits, approval steps) with compliance counsel before producing a run.
• For the UAE, confirm current hospitality and gift-value rules with compliance counsel given the detailed, evolving nature of the Code of Ethics.
• For Iraq, treat the absence of a clearly documented framework as a reason for more caution, not less — confirm with local counsel rather than assuming no rules apply.
• Across all markets, international or multinational pharmaceutical clients with U.S. or EU reporting lines may still apply the stricter PhRMA- or EFPIA-style internal standard globally, regardless of local rules — worth confirming with each specific client's own policy before producing an order.

Where Promotional Products Still Work Legitimately

Even in Turkey's stricter environment, the restriction is specific to items directed at prescribing healthcare professionals — it doesn't eliminate promotional products from the sector entirely. Legitimate, compliant applications include:

• Product-name-branded items within the Saudi SFDA code's conditions. As covered above, Saudi Arabia's framework specifically permits in-kind gifts bearing the product's trade or generic name — a real, usable channel for pharmaceutical clients marketing there, distinct from generic company-branded swag and subject to the code's other conditions.
• Employee engagement and internal culture. Onboarding kits, service anniversaries, and internal recognition programs for pharmaceutical company staff fall outside HCP-marketing restrictions entirely across every market covered here.
• B2B relationships with distributors and non-clinical business partners. Promotional items for wholesalers, pharmacies (within any applicable value caps, as in the UAE), and other business relationships not involving individual prescribing decisions generally follow standard B2B gifting norms.
• Trade shows and industry conferences. Booth giveaways at industry, investor, or business-focused pharmaceutical conferences — as opposed to clinical/CME events aimed at prescribers — typically fall under standard promotional marketing practice, subject to each market's specific conference/congress rules (Turkey, for instance, carves out an exception for international congresses held in-country).
• Patient support and education programs, where items are educational in nature and provided under specific, compliance-reviewed program rules.
• Consumer-facing and OTC (over-the-counter) brands, where local rules permit consumer advertising — noting that several markets covered here, including Turkey and Saudi Arabia, restrict or prohibit consumer-directed pharmaceutical advertising as a separate matter from HCP gifting.

A Practical Example

A pharmaceutical company operating across Turkey and Saudi Arabia runs two clearly different programs to stay compliant in each market: for its Turkish sales force, all HCP-facing materials go through a compliance review with zero branded promotional items included, in line with Article 6/8's near-total gift prohibition. For its Saudi operations, the company works with legal counsel to produce a small run of items bearing the specific product's trade name, within the SFDA code's documented conditions — a compliant channel Turkey's rules don't allow. Across both markets, the company separately orders branded notebooks and drinkware for its own regional sales conference, which falls outside HCP restrictions in every market since the recipients are employees, not external healthcare professionals.

Compliance Checklist Before Any Pharma-Sector Promotional Order

• [ ] Who is the actual recipient — a prescribing healthcare professional, a patient, an employee, a distributor, or a general consumer?
• [ ] Which specific country's rules apply — Turkey, Saudi Arabia, UAE, Iraq, or another market, given how much the framework differs across them?
• [ ] Has legal/compliance confirmed the specific program against that market's current code, not just a general assumption?
• [ ] If a branded item is planned for Saudi Arabia, does it carry the specific product's trade or generic name as the code requires?
• [ ] Does the client have its own internal global policy (common for multinational pharma companies) that may be stricter than local law?

In Summary

Promotional products remain a legitimate marketing tool in the pharmaceutical sector across Turkey, Iraq, and the Gulf — but the rules differ meaningfully by country, from Turkey's near-total prohibition on gifts to prescribers to Saudi Arabia's more structured allowance for product-name-branded items. Getting the country-specific distinction right, rather than applying one regional assumption, protects the company from real compliance risk while still capturing the promotional opportunities each market genuinely allows.

Planning a compliant promotional or employee gifting program for your pharma or healthcare-adjacent business? Request a quote and let Pen Promo help scope a program appropriate to your audience.